Detalhe da pesquisa
1.
Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model.
Clin Infect Dis
; 73(11): e4260-e4268, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33211860
2.
Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial.
Lancet
; 395(10242): 1998-2007, 2020 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534628
3.
Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.
Clin Infect Dis
; 70(5): 748-753, 2020 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30953061
4.
A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.
Clin Infect Dis
; 69(12): 2082-2090, 2019 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770534
5.
Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.
Clin Infect Dis
; 60(5): 693-702, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25416753
6.
The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts.
Clin Infect Dis
; 58(2): 214-24, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24186906
7.
Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers.
mBio
; 15(2): e0237223, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193710
8.
Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 Months.
medRxiv
; 2023 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904956
9.
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States.
Sci Transl Med
; 13(601)2021 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158410
10.
Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States.
medRxiv
; 2021 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33532807
11.
Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model.
Nat Med
; 26(8): 1240-1246, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601336
12.
Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.
mBio
; 9(1)2018 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29362240
13.
Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model.
mBio
; 7(2): e00417-16, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27094330